Marissa Fox


Dry Eye Linked to Poor Sleep Quality

All components of sleep quality were reduced significantly in individuals with dry eye disease.

Nina Cosdon


Certain Factors May Increase Long COVID Risk in Children

Children who tested positive were more likely to report long COVID symptoms at 90 days than children who tested negative.

Dan Langerman, Langermania


Now #Trending: Picking and Choosing Items to Stock the Front-End

Tapping into nostalgia is one way to guide front-end stock choices.

Brandon Daniell


Texting Can Boost Revenue and Patient Care

Eight ways texting can improve patient retention and boost revenue.

Tony Hagen


Sickle Cell Disease Finally Getting Its Due

Two possibly curative gene therapies for the disease, which disproportionately affects Black people, are under consideration by the FDA.

Brian Miller, MD, PhD, MPH


The Effects of Psychedelics in Healthy Participants

In a well-blinded study, researchers investigated and directly compared the acute effects of LSD and psilocybin in healthy participants.

Russ Conroy


FDA Grants Priority Review to Liso-Cel in Relapsed/Refractory CLL/SLL

The FDA acceptance marks the first step in addressing the unmet need for a lasting treatment option for patients with relapsed/refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.

Madeline Colli


Healthcare Provider-Focused Medical Cannabis Research Study Launched by Cannabis Center of Excellence, Medicinal Genomics, and UMass Dartmouth

The Cannabis Center of Excellence, Inc., Medicinal Genomics, and UMass Dartmouth have established the Healthcare Provider Knowledge, Attitudes, Practices Related to Medical Cannabis Research Study to help better understand the experiences of healthcare providers have seen with medical cannabis.

Steve Riddle, PharmD, MSIM, FASHP, BCPS


The Pharmacist’s Role Beyond COVID-19

Amid the pandemic, how effectively pharmacists embraced their role as frontline care providers could change the profession forever.

Samantha Troy, 2021 PharmD candidate


Melphalan Flufenamide for Relapsed or Refractory Multiple Myeloma

Melphalan flufenamide (Pepaxto; Oncopeptides AB) in combination with dexamethasone was granted accelerated approval on February 26, 2021, by the FDA for adult patients with relapsed or refractory multiple myeloma.

Ginny Langbehn


Thriving in a Digital World: Marketing Strategies for Independent Pharmacies

Cut through the online noise with these digital marketing tips for your independent pharmacy.

Kevin Klembczyk, MD


Cannabinoid Hyperemesis Syndrome: Diagnosis and Management

A deep dive for pharmacists into this frequently debilitating disorder

Christine Payne


Best Practices on Discussing Birth Control for Adolescents

There are numerous methods of contraception available for adolescents.

Colin Turnbull, PharmD candidate


The Evolution of Pharmacogenomics

Pharmacogenomics provides an opportunity for pharmacists to enhance their role in patient care.

Jonna Lorenz


Symptom Scoring Framework Helps Formalize Definition of Long COVID

Finalizing a definition for postacute sequelae of SARS-CoV-2 infection will lead to high-quality care and treatment for patients suffering from the condition.

Jeffrey Fitzgerald, JD


National Pharmacy Chain Opioid Settlements Poised to Affect Independent Pharmacies

Stipulations of the settlements include data reporting, annual training, and an independent compliance officer.

Rich Parker, MD


Understanding What Vaccines Could Mean for Long COVID

Research suggests that COVID-19 vaccination may serve a therapeutic effect, possibly reducing the risk of developing long COVID when administered to those currently infected.

Joseph P. Nathan, PharmD, MS


Probiotics for the Prevention of Pediatric Antibiotic-Associated Diarrhea

Evidence of the relationship between probiotics and antibiotics is lacking.

Morgan Petronelli


FDA, CDC Increase Availability of RSV Monoclonal Antibody for Infants

The federal agencies said that they will continue to work closely with manufacturers to maintain the availability of the vaccines through the end of 2023 and early 2024 to meet the demand during the RSV season.

Jennifer Zilka


Independent Pharmacy: A Year in Review & Insights from Abroad

Learn how the challenges and opportunities of the last year have impacted independent pharmacy professionals around the world.

Killian Meara


Chronic Hand Eczema Treatment Shows Positive Results in Phase 3 Trials

Delgocitinib cream from LEO Pharmaceuticals showed superior efficacy compared to cream vehicle and was well tolerated over 16 weeks.

Sebastian Krawiec


FDA: CBD Requires Separate Regulatory Pathway from Dietary Supplements, Food

The agency intends to work with Congress to create a pathway that balances the desire for access with regulatory oversight and risk management.

April Gill


How Pharmacies Can Help Move Health Equity Forward

As costs increase and the number of people in need further outpaces resources, it becomes increasingly urgent to find ways to further extend services to the people who need them.

Rina Lokaj


Early CT Screening Linked to Improved Lung Cancer Survival

Although early computed tomography (CT) screening was associated with improved cure rate for patients with lung cancer, less than 6% of the population that is eligible receives it.

Jessica Li, PharmD candidate


FDA Approves Oral Treatment for Postpartum Depression

Last August, zuranolone (Zurzuvae) became the first FDA-approved pill to treat postpartum depression in adults.

Donna Hallas


Pediatric Vaccines Strongly Recommended, Study Shows

Not every vaccine is required, some are just strongly recommended. Here's what to know about 5 recommended vaccines.

Emma Andrus


Breaking: Benzene Found in Acne Products From Major Brands, Prompts FDA Recall Petition

Following investigation by the independent testing laboratory, Valisure found acne products that contain up to 12 times the allowed of benzene.

Tony P. George, MD, FRCPC


College Students and Misuse of Substances

The prevalence of annual alcohol consumption is highest in full-time college students 1 to 4 years after high school.

Brooke McCormick


Methotrexate, Leflunomide Linked to Higher Risk of Adverse Pregnancy Outcomes in Patients With RA

Due to the increased possibility of adverse pregnancy outcomes associated with methotrexate and leflunomid, it is crucial that patients with rheumatoid arthritis (RA) engage in thorough consultations with their physicians regarding pregnancy planning.

© 2024 MJH Life Sciences

All rights reserved.